ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Vistagen Therapeutics Inc

Vistagen Therapeutics Inc (VTGN)

2.655
-0.105
(-3.80%)
Closed March 10 4:00PM
2.67
0.015
(0.56%)
After Hours: 7:59PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 176k178k277k412k197k84k183k234k
Operating Income -12.24M-7M-6.78M-7.88M-11.36M-12.13M-14.23M-15.12M
Pre Tax Income -12.23M-6.9M-6.59M-6.35M-9.52M-10.73M-12.95M-14.09M
Net Income -12.23M-6.9M-6.59M-6.35M-9.52M-10.73M-12.96M-14.09M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -12.24M-7M-6.78M-7.88M-11.05M-12.13M-14.23M-15.12M
EBITDA -12.21M-6.97M-6.75M-7.85M-11.33M-12.1M-14.19M-15.08M
Year End March 30 2024 20172018201920202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.25M0001.09M1.11M-227k1.06M
Operating Income -10.25M-14.2M-24.56M-20.8M-17.93M-47.78M-59.27M-33.02M
Pre Tax Income -10.25M-14.34M-24.59M-20.77M-17.93M-47.76M-59.24M-29.36M
Net Income -11.62M-15.58M-25.73M-22.04M-42.32M-48.71M-59.25M-29.36M
Preferred Dividends -1.37M-1.23M-1.14M-1.26M-24.39M-946k00
Basic Earnings Per Share (EPS) -0.873-0.576-0.552-0.413-0.229-0.231-0.281-0.948
EBIT -10.25M-14.34M-24.58M-20.8M-17.93M-47.78M-59.27M-32.71M
EBITDA -10.19M-14.12M-24.47M-20.7M-17.82M-47.63M-59.14M-32.89M